Chapter 5 - The Breakthrough in Geneva
Nneka readily agreed to the blood tests for herself and Amara, asking for nothing in return except that Evan get better.
Within forty-eight hours, blood samples were flown via private jet directly to Geneva, Switzerland. Dr. Karl Vance worked around the clock in his state-of-the-art laboratory, funded by a fresh twenty-million-dollar grant from Daniel Kwon’s foundation.
On a rainy Tuesday morning, Daniel’s phone rang. It was Dr. Vance.
“Mr. Kwon,” the doctor’s voice echoed through the speaker, crisp and breathless. “It’s remarkable.”
Daniel stood up from his chair in Room 412. “Tell me.”
“The blood sample from the young girl—Amara—contains a rare genetic antibody variant known as HLA-B57-Enzymatic Alpha. It is an exceptionally rare natural resistance trait,” Dr. Vance explained. “Her genetic markers provide the exact missing blueprint we needed to stabilize the synthetic enzyme structure for your son’s treatment!”
Daniel’s hand trembled slightly against the phone. “Can you make the medicine?”
“We have already synthesized the first trial batch,” Dr. Vance said. “Because your son’s condition is critical, the FDA and European medical boards have granted emergency compassionate use approval. I am getting on a plane to Chicago right now.”
Daniel looked at Evan, who was sleeping peacefully with the rag doll tucked under his arm.
May you like
Twelve million dollars hadn't saved his son. A fortune spent across the globe couldn't buy the single missing piece of the puzzle. It was a chance encounter with a lost girl from West Chicago that held the key to his son's survival.
Daniel lowered his head and, for the first time in thirty years, breathed a quiet prayer of gratitude.
